MIR3613

Across TCGA pan-cancer cohorts, MIR3613 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR3613 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR3613 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3613 expression acts as an unfavorable survival marker, although some lineages such as PAAD and THYM show a favorable association.

UCEC, CESC, and READ are the cancer types where MIR3613 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.472	0.721	<.001	100	view →
CESC	DFS	Quartile	III,IV	0.456	0.819	<.001	74	view →
READ	OS	Quartile	II,III,IV	0.462	0.807	.002	22	view →
ACC	OS	Tertile	All	0.301	0.716	.003	21	view →
MESO	DFS	Tertile	IV	0.125	0.369	.023	15	view →
OV	OS	Quartile	III,IV	0.311	0.447	.007	12	view →
PAAD	OS	Quartile	All	0.620	0.258	.025	6	view →
THYM	DFS	Median	II,III,IV	0.937	0.567	.020	6	view →
LAML	DFS	Median	All	0.460	0.664	.020	6	view →
LUAD	OS	Quartile	All	0.457	0.338	.032	5	view →
KICH	DFS	Quartile	III,IV	0.079	0.769	.021	3	view →
CHOL	OS	Median	II,III,IV	1.000	0.127	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR3613–UCEC (OS)

Open the UCEC breakdown →